1.
Sureda A, Carrasco M, de Miguel M, Martinez J, Conde E, Sanz M, Diaz-Mediavilla J, Sierra J. Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia. Haematologica 2003; 88(11):1213-1220.